A novel prognostic model for patients with sarcomatoid renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel prognostic model for patients with sarcomatoid renal cell carcinoma

Published:2014-10-19 Issue:3 Volume:115 Page:405-411
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Zhang Ben Y.¹,Thompson R. Houston²,Lohse Christine M.³,Leibovich Bradley C.²,Boorjian Stephen A.²,Cheville John C.⁴,Costello Brian A.¹

Affiliation:

1. Department of Oncology; Mayo Clinic; Rochester MN USA

2. Department of Urology; Mayo Clinic; Rochester MN USA

3. Division of Biomedical Informatics and Statistics; Mayo Clinic; Rochester MN USA

4. Department of Pathology; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12781/fullpdf

Reference22 articles.

1. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy;Cangiano;J Clin Oncol,1999

2. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases;Peralta-Venturina;Am J Surg Pathol,2001

3. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome;Cheville;Am J Surg Pathol,2004

4. Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance;Shuch;BJU Int,2011

5. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases;Abel;BJU Int,2012

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study);International Journal of Cancer;2024-09-07

2. Own experience of using combination therapy in the first line of treatment of metastatic renal cell carcinoma;Meditsinskiy sovet = Medical Council;2024-07-24

3. Sarcomatoid and Rhabdoid Renal Cell Carcinoma;American Journal of Surgical Pathology;2024-05-13

4. Deciphering the molecular landscape: integrating single-cell transcriptomics to unravel myofibroblast dynamics and therapeutic targets in clear cell renal cell carcinomas;Frontiers in Immunology;2024-03-18

5. Immunotherapy treatment for sarcomatoid renal cell carcinoma: case report and literature review;Annals of Medicine & Surgery;2024-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3